Partner Investment Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Partner Investment Management’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,634	Closed	-$47K	–	130
2018 Q3	$47K	Sell	2,634 -29,711	-92%	-$510K	0.04%	111
2018 Q2	$446K	Buy	32,345 +4,141	+15%	+$49.1K	0.36%	81
2018 Q1	$256K	Buy	+28,204	New	+$156K	0.28%	73

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Partner Investment Management's ECYT Position: Q4 2018 in Review

Partner Investment Management sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 2,634 shares — an estimated $47K sold.

Partner Investment Management first reported a position in ECYT in Q1 2018 and held it in 3 quarters. The position peaked at $446K in Q2 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Partner Investment Management reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Partner Investment Management sold 2,634 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $47K.
Partner Investment Management first reported a position in Endocyte, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
Partner Investment Management's Endocyte, Inc. Common Stock position peaked at $446K in Q2 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Partner Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.